Many eczema patients skip the mental health talk. Learn how to discuss anxiety and depression with your dermatologist to unlock better treatment options and systemic therapies.

Dr Geng discusses his research from AAAAI Annual Meeting, which explored the relationship between atopic dermatitis and comorbid atopic conditions.

Lebrikizumab is an interleukin-13 antagonist approved as Ebglyss for the treatment of adults and pediatric patients with moderate to severe atopic dermatitis.

Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have ...

The six-time PGA Tour winner once suffered from seborrheic dermatitis, a chronic inflammatory disease that causes dandruff, ...

While "seborrheic dermatitis" (seb derm) may not be a household name, one of its most common visible symptoms—flakes that may ...

Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...

The skin microbiome plays a central role in the pathogenesis of atopic dermatitis (AD), but most studies have focused on high-income populations of European ancestry. Microbiome data from tropical and ...

Switching works: Nearly 80% of patients who failed to reach EASI 75 on dupilumab achieved EASI 75 by 16 weeks after switching to upadacitinib. Rapid itch relief: Clinically meaningful itch improvement ...

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease driven by skin-homing memory T cells. Recent evidence suggests that a subset of tissue-resident memory T (Trm) cells can ...

Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people. As many as one in two people aged over 60 suffer from some form of eczema. A ...